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Background:  Trastuzumab prolongs survival in some breast cancer, at a risk of cardiotoxicity (ctox). Myocardial imaging permits early detection 
of ctox, when treatment is most likely to be successful, but the optimal marker is unclear. We sought the optimal myocardial deformation index for 
predicting 12m ctox.
Methods:  We studied 100 women (51±12 y) receiving chemotherapy; 46 received simultaneous anthracyline and trastuzumab. Conventional echo 
(mitral annular s’ and e’ velocity) and myocardial deformation indices (global longitudinal peak systolic strain [GLS], strain rate [SR-s] and early 
diastolic strain rate [SR-e]) from speckle tracking were measured at baseline, 6 and 12m. Ctox was defined by a decrement of EF >10%.
Results:  Twenty pts (20%) developed ctox. Compared to pts with normal function at 12m, pts with ctox had larger change at 6m for GLS 
(-1.1±19% vs -16.4±14%, p<0.001), SR-s (-3.3±20% vs -23.2±19%, p=0.001), SR-e (4.0±30% vs -17.1±23%, p=0.003) and s’ (-10.1±20% vs 
-22.6±15%, p=0.004). SR-s was the strongest predictor of ctox, with an area under the receiver operating characteristic (ROC) curve of 0.77 (best 
cut-point -12.3%, sensitivity 75%, specificity 72%). In sequential Cox models (Figure), the model based on clinical data (overall 2, 13.7) was 
improved by s’ (19.0, p=0.021) and further increased by either GLS (19.5, p=0.016) or SR-s (22.7, p=0.003).
Conclusion:  GLS and SR-s can be early and incremental predictors for chemotherapy induced cardiotoxicity in breast cancer patients.
 
